Total Payments
$2,354
2024 Payments
$168.74
Companies
23
Transactions
187
Medicare Patients
118
Medicare Billing
$37,779
Payment Breakdown by Category
Food & Beverage$2,349 (99.8%)
Education$5.12 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,349 | 185 | 99.8% |
| Education | $5.12 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $404.85 | 40 | $0 (2024) |
| Egalet US Inc | $334.43 | 38 | $0 (2018) |
| Horizon Therapeutics plc | $247.74 | 17 | $0 (2022) |
| Horizon Pharma plc | $237.32 | 19 | $0 (2018) |
| ARBOR PHARMACEUTICALS, INC. | $159.92 | 11 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $120.29 | 9 | $0 (2020) |
| Purdue Pharma L.P. | $115.86 | 7 | $0 (2018) |
| DePuy Synthes Sales Inc. | $115.66 | 5 | $0 (2023) |
| Daiichi Sankyo Inc. | $113.99 | 11 | $0 (2018) |
| Kaleo, Inc. | $78.84 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $168.74 | 17 | Collegium Pharmaceutical, Inc. ($168.74) |
| 2023 | $190.86 | 11 | Collegium Pharmaceutical, Inc. ($73.59) |
| 2022 | $55.82 | 3 | Neurocrine Biosciences, Inc. ($27.92) |
| 2021 | $277.34 | 19 | Horizon Therapeutics plc ($155.84) |
| 2020 | $112.43 | 7 | PFIZER INC. ($32.76) |
| 2019 | $200.14 | 13 | Collegium Pharmaceutical, Inc. ($58.53) |
| 2018 | $427.91 | 30 | Daiichi Sankyo Inc. ($113.99) |
| 2017 | $921.02 | 87 | Egalet US Inc ($295.93) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $9.54 | General |
| Category: Opioid Analgesic | ||||||
| 11/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Opioid Analgesic | ||||||
| 10/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.63 | General |
| Category: Opioid Analgesic | ||||||
| 09/26/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Opioid Analgesic | ||||||
| 09/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $11.41 | General |
| Category: Opioid Analgesic | ||||||
| 08/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.99 | General |
| Category: Opioid Analgesic | ||||||
| 07/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.80 | General |
| Category: Opioid Analgesic | ||||||
| 06/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.91 | General |
| Category: Opioid Analgesic | ||||||
| 06/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.15 | General |
| Category: Opioid Analgesic | ||||||
| 05/23/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $10.23 | General |
| Category: Opioid Analgesic | ||||||
| 04/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $6.85 | General |
| Category: Opioid Analgesic | ||||||
| 04/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.99 | General |
| Category: Opioid Analgesic | ||||||
| 03/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $5.09 | General |
| Category: Opioid Analgesic | ||||||
| 02/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.55 | General |
| Category: Opioid Analgesic | ||||||
| 02/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.35 | General |
| Category: Opioid Analgesic | ||||||
| 02/08/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.55 | General |
| Category: Opioid Analgesic | ||||||
| 01/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.44 | General |
| Category: Opioid Analgesic | ||||||
| 12/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Gastroenterology | ||||||
| 11/29/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Gastroenterology | ||||||
| 11/08/2023 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Sports Early Intervention | ||||||
| 10/24/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.77 | General |
| Category: Opioid Analgesic | ||||||
| 09/19/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/07/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.15 | General |
| Category: Opioid Analgesic | ||||||
| 08/22/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/27/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 81 | 375 | $44,375 | $20,905 |
| 2022 | 1 | 13 | 77 | $17,325 | $9,295 |
| 2020 | 2 | 24 | 93 | $19,350 | $7,580 |
Total Patients
118
Total Services
545
Medicare Billing
$37,779
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 119 | $26,775 | $12,988 | 48.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 12 | 17 | $7,650 | $3,984 | 52.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 12 | 17 | $4,250 | $1,807 | 42.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,748 | 48.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 60 | $600.00 | $362.34 | 60.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 150 | $1,500 | $14.48 | 1.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 77 | $17,325 | $9,295 | 53.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 72 | $16,200 | $6,372 | 39.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 21 | $3,150 | $1,208 | 38.3% |
About Dr. Deepak Vasishtha, MD
Dr. Deepak Vasishtha, MD is a Physical Medicine & Rehabilitation healthcare provider based in Nanuet, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114950540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deepak Vasishtha, MD has received a total of $2,354 in payments from pharmaceutical and medical device companies, with $168.74 received in 2024. These payments were reported across 187 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,349).
As a Medicare-enrolled provider, Vasishtha has provided services to 118 Medicare beneficiaries, totaling 545 services with total Medicare billing of $37,779. Data is available for 3 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Nanuet, NY
- Active Since 07/09/2006
- Last Updated 04/11/2008
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1114950540
Products in Payments
- XTAMPZA (Drug) $284.47
- ARYMO ER (Drug) $196.95
- DUEXIS (Drug) $177.12
- Horizant (Drug) $146.72
- PENNSAID (Drug) $130.51
- RAYOS (Drug) $123.06
- MOVANTIK (Drug) $120.29
- ORTHOVISC (Device) $115.66
- Morphabond ER (Drug) $113.99
- Xtampza ER (Drug) $91.25
- OXAYDO (Drug) $89.66
- SYMPROIC (Drug) $80.68
- Evzio (Drug) $78.84
- SEGLENTIS (Drug) $63.60
- VIMOVO (Drug) $54.37
- Levorphanol (Drug) $50.76
- SPRIX (Drug) $47.82
- RELISTOR (Drug) $45.76
- HYSINGLA ER (Drug) $35.18
- BELBUCA (Drug) $34.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.